z-logo
open-access-imgOpen Access
Identification of Interferon-Stimulated Gene 15 as an Antiviral Molecule during Sindbis Virus Infection In Vivo
Author(s) -
Deborah J. Lenschow,
Nadia V. Giannakopoulos,
Lacey J. Gunn,
Christine Johnston,
Andy K. O'Guin,
Robert E. Schmidt,
Beth Levine,
Herbert W. Virgin
Publication year - 2005
Publication title -
journal of virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.617
H-Index - 292
eISSN - 1070-6321
pISSN - 0022-538X
DOI - 10.1128/jvi.79.22.13974-13983.2005
Subject(s) - isg15 , sindbis virus , biology , interferon , virology , virus , interferon stimulated gene , alphavirus , viral replication , antiviral protein , innate immune system , gene , immune system , ubiquitin , immunology , genetics , rna
The innate immune response, and in particular the alpha/beta interferon (IFN-α/β) system, plays a critical role in the control of viral infections. Interferons α and β exert their antiviral effects through the induction of hundreds of interferon-induced (or -stimulated) genes (ISGs). While several of these ISGs have characterized antiviral functions, their actions alone do not explain all of the effects mediated by IFN-α/β. To identify additional IFN-induced antiviral molecules, we utilized a recombinant chimeric Sindbis virus to express selected ISGs in IFN-α/β receptor (IFN-α/βR)−/− mice and looked for attenuation of Sindbis virus infection. Using this approach, we identified a ubiquitin homolog, interferon-stimulated gene 15 (ISG15), as having antiviral activity. ISG15 expression protected against Sindbis virus-induced lethality and decreased Sindbis virus replication in multiple organs without inhibiting the spread of virus throughout the host. We establish that, much like ubiquitin, ISG15 requires its C-terminal LRLRGG motif to form intracellular conjugates. Finally, we demonstrate that ISG15's LRLRGG motif is also required for its antiviral activity. We conclude that ISG15 can be directly antiviral.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here